300 related articles for article (PubMed ID: 18534276)
21. Istaroxime: A rising star in acute heart failure.
Aditya S; Rattan A
J Pharmacol Pharmacother; 2012 Oct; 3(4):353-5. PubMed ID: 23326115
[TBL] [Abstract][Full Text] [Related]
22. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock.
Metra M; Chioncel O; Davison B; Filippatos G; Mebazaa A; Pagnesi M; Adamo M; Novosadova M; Ponikowski P; Simmons P; Soffer J; Simonson S; Cotter G
J Card Fail; 2023 Jul; 29(7):1097-1103. PubMed ID: 37075941
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
Baruch L; Patacsil P; Hameed A; Pina I; Loh E
Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
[TBL] [Abstract][Full Text] [Related]
25. Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model.
Rocchetti M; Alemanni M; Mostacciuolo G; Barassi P; Altomare C; Chisci R; Micheletti R; Ferrari P; Zaza A
J Pharmacol Exp Ther; 2008 Sep; 326(3):957-65. PubMed ID: 18539651
[TBL] [Abstract][Full Text] [Related]
26. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
[TBL] [Abstract][Full Text] [Related]
27. Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes.
Gheorghiade M; Sabbah HN
Am J Cardiol; 2007 Jan; 99(2A):1A-3A. PubMed ID: 17239700
[No Abstract] [Full Text] [Related]
28. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction.
Gheorghiade M; Greene SJ; Ponikowski P; Maggioni AP; Korewicki J; Macarie C; Metra M; Grzybowski J; Bubenek-Turconi SI; Radziszewski W; Olson A; Bueno OF; Ghosh A; Deckelbaum LI; Li LY; Patel AR; Koester A; Konstam MA
Eur J Heart Fail; 2013 Jun; 15(6):679-89. PubMed ID: 23471413
[TBL] [Abstract][Full Text] [Related]
30. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs.
Masutani S; Cheng HJ; Hyttilä-Hopponen M; Levijoki J; Heikkilä A; Vuorela A; Little WC; Cheng CP
J Pharmacol Exp Ther; 2008 Apr; 325(1):236-47. PubMed ID: 18174383
[TBL] [Abstract][Full Text] [Related]
31. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
33. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
[TBL] [Abstract][Full Text] [Related]
34. Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
Campia U; Nodari S; Gheorghiade M
Curr Heart Fail Rep; 2010 Sep; 7(3):100-9. PubMed ID: 20625945
[TBL] [Abstract][Full Text] [Related]
35. Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomised trial.
Fredholm M; Jörgensen K; Houltz E; Ricksten SE
Acta Anaesthesiol Scand; 2018 Oct; 62(9):1246-1254. PubMed ID: 29926912
[TBL] [Abstract][Full Text] [Related]
36. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
Lunghetti S; Palmerini E; Urselli R; Maffei S; Guarino E; Focardi M; Mondillo S; Favilli R
Cardiol J; 2011; 18(5):532-7. PubMed ID: 21947989
[TBL] [Abstract][Full Text] [Related]
37. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
Zile MR; Kjellstrom B; Bennett T; Cho Y; Baicu CF; Aaron MF; Abraham WT; Bourge RC; Kueffer FJ
Circ Heart Fail; 2013 May; 6(3):508-16. PubMed ID: 23515277
[TBL] [Abstract][Full Text] [Related]
38. Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure.
Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Schaefer HG; Mueck W; Bornemann M; Pouleur H
J Am Coll Cardiol; 1997 Dec; 30(7):1751-7. PubMed ID: 9385903
[TBL] [Abstract][Full Text] [Related]
39. Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity.
Alemanni M; Rocchetti M; Re D; Zaza A
J Mol Cell Cardiol; 2011 May; 50(5):910-8. PubMed ID: 21354172
[TBL] [Abstract][Full Text] [Related]
40. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
